Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Verogen and QIAGEN Partner to Deliver Innovative Solutions for Human Identification Laboratories
San Diego & HILDEN, Germany & GERMAN TOWN, Md - (BUSINESS WIRE) — QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen today announced a partnership to provide laboratories with superior tools and comprehensive support for implementing next-generation sequencing (NGS) human i [...]
bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe
Marcy l’Étoile, France and Mountain View, California – June 29th, 2021 – bioMérieux, a world leader in the field of in vitro diagnostics, and Specific Diagnostics, a company bringing unique in vitro diagnostic systems to clinical microbiology, announce that bioMérieux will distribute Specific Diagno [...]
Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
Madison, WI, USA, & San Diego, CA, USA June 28, 2021 — Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration to discover and develop novel peptide-based radiopharmaceuticals for treatment of cancer. “We are excited to welcome RayzeBio to our growin [...]